Hemodynamic Resuscitation and Monitoring in Early Sepsis
NCT04143035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-10-24
Summary
"Hemodynamic Resuscitation and Monitoring in Early Sepsis (HERMES Study)" involves recording of patient's medical data related to that has been collected as part of his/her routine medical care in ICU.
Presently there is no data from Indian ICUs on the way patients in early sepsis are resuscitated and monitored. There may exist a wide variation in clinical practice. The investigators would like to conduct an observational study in various levels of Indian ICUs, to prospectively collect data on adult patients admitted to ICU with early sepsis in a 60-day window period. Investigator would like to study the hemodynamic resuscitation and monitoring performed in these patients. In addition, Investigator would like to identify factors associated with improved outcomes and achieving the goals of the sepsis bundles in one, three and six hours.
The objectives of the study is to capture the patient characteristics and hemodynamic resuscitation and monitoring practices in patients presenting with early sepsis and hypotension to Indian ICUs
Investigator plan to recruit 50 -100 centers nationwide. Each center will be asked to collect data from at least 10 patients in a maximum time window of 60 days. A convenience sample of minimum 500 patients presenting to ICU with suspected sepsis and hypotension will be taken.
Each Centre will guarantee the integrity of data collection and ensure timely completion of the case record forms. Each center will select a 60 day window period for patient recruitment. The start date may be anytime any time between 1st August to 15th October 2019. Therefore, the recruitment window period will end for a respective centre, anytime between 30th September and 14th December 2019, depending on the start date. All consecutive patients in the 60-day period will be screened and those eligible will be enrolled.
This is an ISCCM(Indian Society of Critical Care Medicine) Research Committee funded study. The ISCCM will fund the Principal Investigator for all expenses related software development, website hosting, secretarial assistance and miscellaneous expenses related to the conduct of the study, data analysis and publication. No funding will be given to the investigators from the various participating centers for contributing data.
Conditions
- Septic Shock
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
-
Indian Society of Critical Care Medicine
collaborator OTHER -
Tata Memorial Centre
lead OTHER
Principal Investigators
-
Sheila N Myatra, MD · Tata Memorial Hospital, Parel, Mumbai-12
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-22
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- India
Study Locations
More Related Trials
-
Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone
NCT06537180 ·Status: COMPLETED
-
COrporeal Compression at the ONset of Severe Sepsis and Septic Shock
NCT02656654 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Early Lactate Clearance Rate in Sepsis
NCT04192279 ·Status: UNKNOWN
-
Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients
NCT06363149 ·Status: RECRUITING
-
Severe Sepsis/Septic Shock on Admission to the General Surgical ICU
NCT01363635 ·Status: RECRUITING
-
Comparison of Radial and Femoral Artery Site Invasive Blood Pressure Measurement in Septic Shock Patients
NCT03475667 ·Status: COMPLETED
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?
NCT05557461 ·Status: UNKNOWN
-
German Lactat Clearance in Severe Sepsis
NCT01929772 ·Status: COMPLETED
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
NCT02114710 ·Status: COMPLETED ·Phase: PHASE3
-
Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis
NCT00484133 ·Status: UNKNOWN ·Phase: PHASE4
-
Fluid Overload Quantification in Septic Shock
NCT04114162 ·Status: COMPLETED
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock
NCT04647552 ·Status: COMPLETED
-
Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic Shock
NCT02030158 ·Status: COMPLETED
-
Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
NCT06860438 ·Status: RECRUITING
-
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
NCT07313670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Outcomes of Severe Sepsis Patients in Surgical Intensive Care Units
NCT01919138 ·Status: COMPLETED
-
Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study
NCT06937918 ·Status: RECRUITING ·Phase: NA
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under Estimated
NCT05184296 ·Status: RECRUITING ·Phase: NA
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2